Reuters logo
BRIEF-Impax reports FDA approval of its AB rated generic concerta extended-release tablets CII
July 17, 2017 / 11:50 AM / 5 months ago

BRIEF-Impax reports FDA approval of its AB rated generic concerta extended-release tablets CII

July 17 (Reuters) - Impax Laboratories Inc:

* Impax announces FDA approval of its AB rated generic concerta® (methylphenidate hydrochloride) extended-release tablets CII

* Says don’t anticipate sales of generic concerta to meaningfully impact earnings in 2017​

* Says ‍preparing for launch including working to secure api quota and currently expect to launch by end of this year​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below